Bumper Offer - Urjas oil Just @ Rs. 1
Tretiva 5 capsule is a prescription medicine that is available as a Capsule. It is primarily used for the treatment of Pimples.
The optimal dosage of Tretiva 5 capsule is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Tretiva 5 capsule have been listed ahead. Normally, these side effects of Tretiva 5 capsule are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Tretiva 5 capsule has a Severe effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Tretiva 5 capsule related warnings talks about Tretiva 5 capsule's effects on the liver, heart and kidney.
Tretiva 5 capsule is not recommended if you suffer from certain medical conditions as it can have adverse effects. Depression are examples of such conditions. Other conditions have been mentioned below in the Tretiva 5 capsule contraindications section.
Drug reaction of Tretiva 5 capsule with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Tretiva 5 capsule is safe while driving, and is addiction.
Tretiva 5 capsule is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Tretiva 5 capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Tretiva. If you are pregnant, do not take Tretiva without a doctor's advice.
Is the use of Tretiva 5 capsule safe during breastfeeding?
Tretiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Tretiva 5 capsule on the Kidneys?
Tretiva has very mild side effects on the kidneys.
What is the effect of Tretiva 5 capsule on the Liver?
There may be an adverse effect on the liver after taking Tretiva. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Tretiva 5 capsule on the Heart?
There may be an adverse effect on the heart after taking Tretiva. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Tretiva 5 capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tretiva 5 capsule unless your doctor advises you to do so -
Is this Tretiva 5 capsule habit forming or addictive?
No, you will not get addicted to Tretiva 5 capsule.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Tretiva 5 capsule since it does not cause drowsiness.
Is it safe?
Yes, but take Tretiva 5 capsule only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Tretiva 5 capsule for mental disorders.
Interaction between Food and Tretiva 5 capsule
Some foods when eaten with Tretiva 5 capsule can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Tretiva 5 capsule
Taking Tretiva 5 capsule and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894-895
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Accutane® (isotretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Absorica™ (isotretinoin)